Observational studyBMC anesthesiology2017
The optimum sevoflurane concentration for supraglottic airway device Blockbuster™ insertion with spontaneous breathing in obese patients: a prospective observational study.
Observational study in BMC anesthesiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 17 citations in OpenAlex.
- Predicted effect-site concentrations of remimazolam for i-gel insertion: a prospective randomized controlled study.Journal of clinical monitoring and computing · 2024Trial
- A randomised controlled trial to compare blind intubation success through LMA Blockbuster® and I-Gel® LMA.Anaesthesiology intensive therapy · 2024Trial
- Supraglottic jet oxygenation and ventilation for obese patients under intravenous anesthesia during hysteroscopy: a randomized controlled clinical trial.BMC anesthesiology · 2019Trial
- Airway management for patients with tracheal stenosis and severe scar contracture of the face and neck via bronchoscopy: a case report.Journal of cardiothoracic surgery · 2024Article
- Article
- Long-term high-risk drinking does not change effective doses of propofol for successful insertion of gastroscope in Chinese male patients.BMC anesthesiology · 2022Article
- Article
- Volatile Anesthetics Activate a Leak Sodium Conductance in Retrotrapezoid Nucleus Neurons to Maintain Breathing during Anesthesia in Mice.Anesthesiology · 2020Article
- Comparison of success rate of BlockBusterIndian journal of anaesthesia · 2019Article
- A feasibility study of jaw thrust as an indicator assessing adequate depth of anesthesia for insertion of supraglottic airway device in morbidly obese patients.Chinese medical journal · 2019Article
- Dexmedetomidine reduces sevoflurane ECTherapeutics and clinical risk management · 2019Article
- Comparison of the LMA BlockBuster and intubating LMA as a conduit to blind tracheal intubation.Journal of anaesthesiology, clinical pharmacologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAirway management of the obese patient presenting for surgery is more likely to be a challenging problem. Supraglottic airway device has been adopted as a bridge to connect ventilation and tracheal intubation in obese patients who would be suffered with difficult intubation. The optimum sevoflurane concentration for supraglottic airway device insertion allowing spontaneous breathing in 50% of obese patients (ED
methodsThirty elective obese patients (body mass index 30-50 kg/m
resultsThe ED
conclusionWe conclude that the optimum end-tidal sevoflurane concentration required for the supraglottic airway device Blockbuster™ insertion allowing spontaneous breathing in 50% of obese patients (ED
trial registrationChinese Clinical Trial Registry, ChiCTR-IPR-16009071 , Registered on 24 August 2016.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.